Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine, Analytical Science, Bioprocessing - Upstream & Downstream, Technology and Equipment

Fiber-based chromatography to improve productivity in downstream AAV processing

sponsored by Cytiva

Available On-Demand

December 2, 2020 at 17:00 UK

Speaker: Dr. Peter Guterstam
Product Manager, Next Generation Resins and Technologies, Cytiva

As more AAV-based gene therapies move towards the clinic, there is a growing need for scalable and cost-effective production processes that maintain virus quality. In downstream processing, the capture chromatography step is a bottleneck. To address the need for higher productivity, we are developing a novel fiber technology, Fibro, which uses a proprietary structure that overcomes the diffusional and flow limitations of packed- bed chromatography. The fiber structure is highly open to facilitate mass transfer without diffusion, as with membrane and monolith technologies. Unlike those options, the Fibro structure provides a large surface area resulting from an additive manufacturing process.

Available On-Demand

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register